MGX
Metagenomi, Inc.
1.10$
+1.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
Metagenomi, Inc. (MGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at -0.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 12 | 11 | 20 | 12 | 9.6 | 4.1 | 8.5 | 8.7 | 3.9 | 1.2 | -0.3 | 14 | |
| 27 | 25 | 31 | 1.3 | – | 1.5 | 25 | 23 | 1.3 | 1.3 | 0.9 | – | – | |
| -14 | -12 | -20 | 20 | 12 | 9.6 | -21 | -14 | 7.3 | 2.6 | 0.4 | -0.3 | 10 | |
| 27 | 25 | 31 | 28 | 26 | 23 | 25 | 23 | 24 | 22 | 19 | 23 | 87 | |
| 7.9 | 7.8 | 8.8 | 8.6 | 7.6 | 7.1 | 6.8 | 7.0 | 6.2 | 6.8 | 6.5 | 6.0 | 26 | |
| 7.9 | 7.8 | 8.8 | 37 | 34 | 30 | 6.8 | 7.0 | 30 | 27 | 25 | 29 | 111 | |
| -22 | -20 | -29 | -17 | -22 | -21 | -28 | -21 | -23 | -24 | -25 | -29 | -101 | |
| 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| -19 | -17 | -25 | -13 | -21 | -25 | -25 | -20 | -21 | -22 | -23 | -27 | -94 | |
| 1.2 | 2.7 | -3.9 | -2.2 | -2.1 | -1.2 | 0.1 | 0.0 | -0.2 | 0.0 | 0.0 | – | – | |
| -20 | -19 | -25 | -11 | -19 | -23 | -25 | -20 | -20 | -23 | -23 | -27 | -93 | |
| -17 | -15 | -24 | -12 | -20 | -23 | -24 | -19 | -19 | -21 | -22 | -26 | -88 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.